9 results
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
and/or digoxin level ... 1 — Treat the lungs ... Revascularization, treatment ... #Checklist #CHF ... #Cardiogenic #HeartFailure
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... /ambcarerx #CHF ... #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
: weight gain, lung ... HFrEF may lack lung ... cuffing, Kerley B lines ... Jcortesizaguirr #HFrEF #heartfailure ... #diagnosis #management
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
6th decades of life ... cough, dyspnea, fever ... pattern, irregular lines ... Organizing Pneumonia Treatment ... ILD #diagnosis #management
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
MC: CNS CSF: • ... change in the lungs ... nails, bronchi, lungs ... device removal (if ... Fungal #Diagnosis #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... differential #algorithm #management ... table #foamed #heartfailure ... #chf #criticalcare ... icu #clinical #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... prolonged half-life ... #valleyfever #management ... #treatment #antifungals ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... prolonged half-life ... hypokalemia, phlebitis, fever ... Coccidioidomycosis #pharmacology ... #management #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management